Advancements in Obesity Management (AOM)
Published: 20 June 2024
-
Views:
2952
-
Likes:
7
-
Views:
2952
-
Likes:
7
-
1h 1mPart 1 Session 1: Obesity as a Disease, Diagnosis and Cardiovascular Disease Risk Naveed Sattar, Harold Bays, Mikhail Kosiborod, Ozden Gokdemir
-
59m 45sPart 2 Session 2: Rapid Fire Sessions - Challenges of Treating Specific CV Disease in Patients With Obesity Naveed Sattar, Linda Mellbin, Neha Pagidipati, Vanita Aroda
-
55m 52sPart 3 Session 3: Healthful Nutrition, Physical Activity, Behaviour Modification and MDT Erin D Michos, Ozden Gokdemir, Lydia Alexander, Liesbeth van Rossum
Overview
The on-demand version of Advancements in Obesity Management (AOM) 2024 explores the intricate links between obesity and cardiovascular disease, providing key insights in evolving diagnostic and treatment strategies.
This event, led by Course Directors Dr Harold Bays (Louisville Metabolic and Atherosclerosis Research Centre, US) and Prof Naveed Sattar (University of Glasgow, UK) brings together a distinguished group of global faculty members who are renowned experts in the field of obesity and cardiovascular disease.
Split into four sessions, the faculty delve into the complexities of obesity and its multifaceted intricacies, spanning medical, surgical, nutritional, psychological and social dimensions for clinicians treating patients with obesity.
The live version of Advancements in Obesity Management was CME-accredited. This on-demand version is not.
Key Learning Objectives
- To understand the complex and multifactorial relationship between obesity and CV disease, including the biological, behavioural and environmental factors that contribute to this relationship
- To understand the impacts of obesity across the CV disease spectrum
- Apply current treatment methodologies to reduce the impact of obesity on CV disease utilising the multidisciplinary team
Target Audience
- Cardiologists
- Primary Care Physicians
- Endocrinologists
- Diabetologists
- Obesity Specialists
More from this programme
Part 1
Session 1: Obesity as a Disease, Diagnosis and Cardiovascular Disease Risk
The panel introduce a patient living with obesity, including current diagnosis and cardiovascular complications of the disease. Furthermore, the emerging data leading to a revolution in the treatment of obesity is discussed.
Part 2
Session 2: Rapid Fire Sessions - Challenges of Treating Specific CV Disease in Patients With Obesity
In the second session, the panel delve into treatment of specific CV diseases in patients living with obesity. Key co-morbidities discussed include diabetes, hypertension, dyslipidemia and thrombosis.
Part 3
Session 3: Healthful Nutrition, Physical Activity, Behaviour Modification and MDT
In this third session, the panel explore the biological, environmental, psychological and social factors contributing to obesity.
Part 4
Session 4: Medical and Procedural Options and the Referral Pathways
In the final session, the panel discuss practical considerations in utilising new pharmacological therapies for treating obesity and cover the extensive development pipeline. The current understanding of clinical outcome data and patient referral criteria are also discussed for surgical approaches.
Faculty Biographies
Harold Bays
Medical Director and President
Dr Harold Bays is Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center, US. He has served as a Principal Investigator for over 600 clinical trials of metabolic therapeutic interventions.
Dr Bays is Board Certified in Internal Medicine and Endocrinology and Metabolism, Diplomate of the American Board of Obesity Medicine, and a Diplomate of the American Board of Clinical Lipidology. He is a Fellow of the Obesity Medicine Association, The Obesity Society, the American College of Cardiology, the American Association of Clinical Endocrinologists, the National Lipid Association, and the American Society of Preventive Cardiology.
Dr Bays has written or served as a contributing author to over 350 scientific manuscripts and book chapters and authored/presented 100’s of scientific abstracts.
Francesco Rubino
Chair of Metabolic and Bariatric Surgery
Prof Francesco Rubino is Chair of Metabolic and Bariatric Surgery at King's College London and Honorary Consultant at King's College Hospital in London, UK.
Alexander Miras
Professor and Consultant in Endocrinology
Alexander Miras is a Professor and Consultant in Endocrinology at Ulster University in Belfast, UK.
Comments